Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Wahed FTSE USA Shariah ETF (HLAL) Price & Performance

BioNTech SE - ADRTrade
Wahed FTSE USA Shariah ETFTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Wahed FTSE USA Shariah ETF — how do they compare? BioNTech SE - ADR trades at $93.34 (market cap $23.31B), while Wahed FTSE USA Shariah ETF trades at $72.96. The key difference: Wahed FTSE USA Shariah ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.

BNTXHLAL
Market Cap
$23.31B
Sector
HealthSector/Thematic
52-Week High
$119.34$73.60
52-Week Low
$83.89$55.52
Enterprise Value
$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

BioNTech (BNTX) trades at $93.27, up 0.51% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 revenue of $106 million, missing expectations, and lowered its full-year sales outlook due to weak COVID-19 vaccine demand. Despite negative net income margins and cash outflows, BNTX maintains a strong cash position of $16.78 billion and is advancing its oncology pipeline with 14 pivotal clinical trials.

The outlook is mixed: analyst consensus is strongly bullish with a $121 price target, but declining COVID revenue and ongoing losses pose significant risks. Investment opportunity hinges on successful pipeline development, while near-term headwinds from vaccine demand softness and leadership transition require careful monitoring.

Wahed FTSE USA Shariah ETF

HLAL trades at $72.95, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bullish trend based on moving averages, though oscillators are neutral. The stock lacks recent fundamental data, with key ratios like P/E and P/S unavailable. A small dividend of $0.02 is scheduled for June 2026, but no recent earnings or cash flow updates are present.

The outlook is mixed due to incomplete financials; technical strength suggests potential upside, but fundamental opacity poses risks. Investors face uncertainty without current revenue or profit metrics, requiring caution until updated SEC filings or analyst reports emerge to assess valuation and growth prospects accurately.

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Wahed FTSE USA Shariah ETF

HLAL is an ETF that invests in Shariah-compliant US companies. It follows a rigorous screening process to exclude businesses involved in non-compliant activities like interest-based finance, alcohol, and gambling.

Read more on HLAL